Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review
Authors:
- 13 August 2023
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 23 (11) , e420-e427
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (1K99CA277136-01)
This publication has 56 references indexed in Scilit:
- Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple MyelomaTransplantation and Cellular Therapy, 2015
- Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center studyCancer, 2014
- Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio‐geo‐demographic factors in the era of novel agentsAmerican Journal of Hematology, 2014
- Multiple Myeloma Treatment Transformed: A Population-Based Study of Changes in Initial Management Approaches in the United StatesJournal of Clinical Oncology, 2013
- Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel-Agent-Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real-World Claims DataThe Oncologist, 2013
- Outcome disparities in multiple myeloma: a SEER‐based comparative analysis of ethnic subgroupsBritish Journal of Haematology, 2012
- Quality of Care for Older Patients With Cancer in the Veterans Health Administration Versus the Private SectorAnnals of Internal Medicine, 2011
- Access to hematopoietic stem cell transplantationCancer, 2010
- Diagnostic delay and complications for older adults with multiple myelomaLeukemia & Lymphoma, 2009
- Chemotherapy and Survival for Patients With Multiple MyelomaAmerican Journal of Clinical Oncology, 2007